Tanvex BioPharma, Inc. (6541.TW) TAI

51.60

+0.2(+0.39%)

Updated at September 08 01:35PM

Currency In TWD

Valuation

Market Cap10.12B
Enterprise Value11.39B
P/E Ratio-8.77
PEG Ratio-0.8
Price/Sales Ratio123.01
Price/Book Ratio2.52
Enterprise/Revenue131.7
Enterprise/EBITDA-14.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-12.64
Operating Margin-11.77

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.45

Income Statement

Revenue34.68M
Revenue/Share0.47
Gross Profit8.29M
EBITDA-1.04B
Net Income-1.38B
Diluted EPS-8.9

Balance Sheet

Total Cash570.97M
Total Cash/Share2.4
Total Debt1.54B
Total Debt/Equity0.32
Current Ratio2.17
Book Value Per Share20.45

Price History

52-Week Change-27.73
52-Week High82
52-Week Low48.1
Moving Average 50 Days53.3
Moving Average 200 Days61.1

Statistics

Average Volume645,236
Shares Outstanding264.61M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor51:50
Last Split DateMarch 27, 2023